Centivax

South San Francisco, CA · Founded 2019 · Privately Held (backing)

Developer of a broad-spectrum vaccine designed to treat and eradicate rapidly mutating pathogens. Centivax is based in South San Francisco, CA and was founded in 2019. Its last reported valuation was $95 million in Jul 2025. It has raised $92 million.

Last reported valuation

$95.0M

Oct 2026

Priced at

—

Total raised

$92.0M

Last round

—

How much has Centivax raised?

$92.0Macross 0 recorded rounds

Free account

More of Centivax with a free account

·The complete investor list: 14 names
·Watch Centivax: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Centivax investors

14 investors are on record for Centivax, including NFX, Amplify Partners, Future Ventures (San Francisco) and Patrick Collison. By type, the record holds 4 venture capital firms and 1 hedge fund.

For fundraisers

Raising for a company like Centivax?

14 investors have backed Centivax.

See all 14 investors →

Frequently asked about Centivax

How much has Centivax raised?: Centivax has raised $92.0M in total across 0 recorded funding rounds.